Skip to main content
SpringerLink
Log in
Book cover

Biochemistry of Drug Resistance pp 197–234Cite as

Drug Resistance in Skin Diseases

  • Chapter
  • First Online:

  • 1023 Accesses

Abstract

Skin is the largest organ of the body and the biggest barrier against pathogens. Skin diseases have become one of the most challenging medical problems in clinical practices, and a tremendous burden to the healthcare system in terms of cost and consumption of institutional resources. The emergence of drug resistance is a threat and concern in various clinical implications of skin diseases, particularly those that have secondary intervention such as chemotherapy, as the main treatment option. Multidrug-resistant organisms include bacteria and other microorganisms that have grown resistance to antimicrobial drugs. Resistance to antimicrobial drugs reduces the effectiveness of treatment and increases the severity of dermatologic diseases. Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococci (VRE), and multidrug-resistant gram-negative rods (MDR GNR) bacteria are the common multidrug-resistant organisms (MDROs). Skin cancers have poor prognosis and treatment options, due to resistance to conventional chemotherapies. The exact mechanisms of resistance in skin cancers are not known, however most tumors likely resist through reduced apoptosis. Many molecular pathways, enzymes and genes are implicated in the process of reduced “apoptosis induction”. Similarly, acyclovir (ACV) and related analogues are successful drugs against HSV infections, however the emergence of drug resistance to ACV has become an obstacle in the treatment of HSV infections, especially in patients with low immunity. In this chapter, we have attempted to discuss major skin diseases and relevant factors that contribute to drug resistance in many dermatologic conditions.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abdul-Karim, R. M., & Cowey, C. L. (2017). Challenging the standard of care in advanced melanoma: Focus on pembrolizumab. Cancer Management and Research, 9, 433.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alter, A., Alcaïs, A., Abel, L., & Schurr, E. (2008). Leprosy as a genetic model for susceptibility to common infectious diseases. Human Genetics, 123, 227–235.

    Article  PubMed  Google Scholar 

  • Amaral, T., & Garbe, C. (2017). Non-melanoma skin cancer: new and future synthetic drug treatments. Expert Opinion on Pharmacotherapy, 18, 689–699.

    Article  CAS  PubMed  Google Scholar 

  • Andrade, J. C., Morais-Braga, M. F. B., Guedes, G. M., Tintino, S. R., Freitas, M. A., Menezes, I. R., & Coutinho, H. D. (2014). Enhancement of the antibiotic activity of aminoglycosides by alpha-tocopherol and other cholesterol derivates. Biomedicine & Pharmacotherapy, 68, 1065–1069.

    Article  CAS  Google Scholar 

  • Anuj, S. A., Gajera, H. P., Hirpara, D. G., & Golakiya, B. A. (2019). Interruption in membrane permeability of drug-resistant Staphylococcus aureus with cationic particles of nano-silver. European Journal of Pharmaceutical Sciences, 127, 208–216.

    Article  CAS  PubMed  Google Scholar 

  • Arias, C. A., & Murray, B. E. (2009). Antibiotic-resistant bugs in the 21st century—a clinical super-challenge. New England Journal of Medicine, 360, 439–443.

    Article  CAS  PubMed  Google Scholar 

  • Ascierto, P. A., Kirkwood, J. M., Grob, J.-J., Simeone, E., Grimaldi, A. M., Maio, M., Palmieri, G., Testori, A., Marincola, F. M., & Mozzillo, N. (2012). The role of BRAF V600 mutation in melanoma. Journal of Translational Medicine, 10, 1–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Autiero, I., Costantini, S., & Colonna, G. (2009). Modeling of the bacterial mechanism of methicillin-resistance by a systems biology approach. PLoS ONE, 4, e6226.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bacon, T. H. et al. (2003). Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clinical Microbiology Reviews, 16(1), 114–128. https://doi.org/10.1128/CMR.16.1.114-128.2003.

  • Barbieri, J. S., Bhate, K., Hartnett, K. P., Fleming-Dutra, K. E., & Margolis, D. J. (2019). Trends in oral antibiotic prescription in dermatology, 2008 to 2016. JAMA Dermatology, 155, 290–297.

    Article  PubMed  PubMed Central  Google Scholar 

  • Beceiro, A., Tomás, M., & Bou, G. (2013). Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clinical Microbiology Reviews, 26, 185–230.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bedel, A. N., Hemmelgarn, T. S., & Kohli, R. (2012). Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: Comparison of prophylactic oral ganciclovir and oral valganciclovir. Liver Transplantation, 18, 347–354.

    Article  PubMed  PubMed Central  Google Scholar 

  • Biroccio, A., Benassi, B., Filomeni, G., Amodei, S., Marchini, S., Chiorino, G., Rotilio, G., Zupi, G., & Ciriolo, M. R. (2002). Glutathione influences c-Myc-induced apoptosis in M14 human melanoma cells. Journal of Biological Chemistry, 277, 43763–43770.

    Article  CAS  PubMed  Google Scholar 

  • Blair, J. M., Richmond, G. E., & Piddock, L. J. (2014). Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiology, 9, 1165–1177.

    Article  CAS  PubMed  Google Scholar 

  • Blair, J. M., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. (2015). Molecular mechanisms of antibiotic resistance. Nature reviews microbiology, 13(1), 42–51.

    Google Scholar 

  • Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000). A family of drug transporters: the multidrug resistance-associated proteins. Journal of the National Cancer Institute, 92, 1295–1302.

    Article  CAS  PubMed  Google Scholar 

  • Boyers, L. N., Karimkhani, C., Naghavi, M., Sherwood, D., Margolis, D. J., Hay, R. J., Williams, H. C., Naldi, L., Coffeng, L. E., & Weinstock, M. A. (2014). Global mortality from conditions with skin manifestations. Journal of the American Academy of Dermatology, 71(1137–1143), e17.

    Google Scholar 

  • Brown, S. K., & Shalita, A. R. (1998). Acne vulgaris. The Lancet, 351, 1871–1876.

    Article  CAS  Google Scholar 

  • Burrel, S., Bonnafous, P., Hubacek, P., Agut, H., & Boutolleau, D. (2012). Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity. Antiviral Research, 96, 386–390.

    Article  CAS  PubMed  Google Scholar 

  • Bush, K., & Jacoby, G. A. (2010). Updated functional classification of β-lactamases. Antimicrobial Agents and Chemotherapy, 54, 969–976.

    Article  CAS  PubMed  Google Scholar 

  • Cardona, A. F., & Wilson, S. E. (2015). Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment. Clinical Infectious Diseases, 61, S69–S78.

    Article  CAS  PubMed  Google Scholar 

  • Casas, A., di Venosa, G., Hasan, T., & Batlle, A. (2011). Mechanisms of resistance to photodynamic therapy. Current Medicinal Chemistry, 18, 2486–2515.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cattamanchi, A., Saracino, M., Selke, S., Huang, M. L., Magaret, A., Celum, C., Corey, L., Wald, A., & Casper, C. (2011). Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men. Journal of Medical Virology, 83, 1696–1703.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chambers, H. F. (1997). Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clinical Microbiology Reviews, 10, 781–791.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chancey, S. T., Zähner, D., & Stephens, D. S. (2012). Acquired inducible antimicrobial resistance in Gram-positive bacteria. Future Microbiology, 7, 959–978.

    Article  CAS  PubMed  Google Scholar 

  • Chen, J., Shao, R., Zhang, X. D., & Chen, C. (2013). Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics. International Journal of Nanomedicine, 8, 2677.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chopra, I. et al. (1992). Tetracyclines, molecular and clinical aspects. The Journal of Antimicrobial Chemotherapy, 29(3), 245–277. https://doi.org/10.1093/jac/29.3.245.

  • Chopra, I., & Roberts, M. (2001). Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiology and Molecular Biology Reviews, 65, 232–260.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coates, R., Moran, J., & Horsburgh, M. J. (2014). Staphylococci: colonizers and pathogens of human skin. Future Microbiology, 9, 75–91.

    Article  CAS  PubMed  Google Scholar 

  • Cogen, A., Nizet, V., & Gallo, R. (2008). Skin microbiota: A source of disease or defence? British Journal of Dermatology, 158, 442–455.

    Article  CAS  PubMed  Google Scholar 

  • Cogen, A. L., Walker, S. L., Roberts, C. H., Hagge, D. A., Neupane, K. D., Khadge, S., & Lockwood, D. N. (2012). Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions. PLoS Neglected Tropical Diseases, 6, e1869.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Collins, P., Larder, B., Oliver, N., Kemp, S., Smith, I., & Darby, G. (1989). Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. Journal of General Virology, 70, 375–382.

    Article  CAS  PubMed  Google Scholar 

  • Cooper, A. J. (1998). Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Medical Journal of Australia, 169, 259–261. https://doi.org/10.5694/j.1326-5377.1998.tb140250.x.

  • Cowey, C. L. (2013). Targeted therapy for advanced Basal-cell carcinoma: vismodegib and beyond. Dermatology and Therapy, 3, 17–31.

    Google Scholar 

  • Danhof, R., Lewis, K., & Brown, M. (2018). Small molecule inhibitors of the hedgehog pathway in the treatment of basal cell carcinoma of the skin. American Journal of Clinical Dermatology, 19, 195–207.

    Article  PubMed  Google Scholar 

  • Davies, J., & Davies, D. (2010). Resistance origins and evolution of antibiotic. Microbiology and Molecular Biology Reviews, 74, 417–433.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • de Clercq, E., & Holý, A. (2005). Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nature Reviews Drug Discovery, 4, 928–940.

    Article  PubMed  CAS  Google Scholar 

  • de Carsalade, G.-Y., Wallach, D., Spindler, E., & Pennec, J. (1997). Daily multidrug therapy for leprosy; results of a fourteen-year experience. International Journal of Leprosy and Other Mycobacterial Diseases, 65, 37.

    PubMed  Google Scholar 

  • De Clercq, E. (2013). Antivirals: past, present and future. Biochemical Pharmacology, 85, 727–744.

    Google Scholar 

  • del Rosso, J. Q., Kircik, L., & Gallagher, C. J. (2015). Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris. The Journal of Clinical and Aesthetic Dermatology, 8, 31.

    PubMed  PubMed Central  Google Scholar 

  • Diekema, D., Pfaller, M., Schmitz, F., Smayevsky, J., Bell, J., Jones, R., Beach, M., & Group, S. P. (2001). Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clinical Infectious Diseases, 32, S114–S132.

    Google Scholar 

  • Drake, A. L., Roxby, A. C., Ongecha-Owuor, F., Kiarie, J., John-Stewart, G., Wald, A., Richardson, B. A., Hitti, J., Overbaugh, J., & Emery, S. (2012). Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial. Journal of Infectious Diseases, 205, 366–375.

    Article  CAS  PubMed  Google Scholar 

  • Dréno, B., Pécastaings, S., Corvec, S., Veraldi, S., Khammari, A., & Roques, C. (2018). Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. Journal of the European Academy of Dermatology and Venereology, 32, 5–14.

    Article  PubMed  Google Scholar 

  • DRÉNO, B. (2016). Bacteriological resistance in acne: a call to action. European Journal of Dermatology, 26, 127–132.

    Google Scholar 

  • Eady, E. A. et al. (1989). Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. The British Journal of Dermatology, 121(1), 51–57. https://doi.org/10.1111/j.1365-2133.1989.tb01399.x.

  • Eady, E. A. (1998). Bacterial resistance in acne. Dermatology, 196, 59–66.

    Google Scholar 

  • Eady, E. A., Cove, J., Holland, K., & Cunliffe, W. (1989). Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. British Journal of Dermatology, 121, 51–57.

    Article  CAS  PubMed  Google Scholar 

  • Eady, E., Jones, C., Gardner, K., Taylor, J., Cove, J., & Cunliffe, W. (1993). Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline. British Journal of Dermatology, 128, 556–560.

    Article  CAS  PubMed  Google Scholar 

  • Eady, E., Bojar, R., Jones, C., Cove, J., Holland, K., & Cunliffe, W. (1996). The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin resistant propionibacteria. British Journal of Dermatology, 134, 107–113.

    Article  CAS  PubMed  Google Scholar 

  • Ekwueme, D. U., Guy JR, G. P., Li, C., Rim, S. H., Parelkar, P., & Chen, S. C. (2011). The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity–United States, 2000 to 2006. Journal of the American Academy of Dermatology, 65, S133. e1-S133. e12.

    Google Scholar 

  • Elion, G. B. (1982). Mechanism of action and selectivity of acyclovir. The American journal of medicine, 73, 7–13.

    Google Scholar 

  • Eroglu, Z., & Ribas, A. (2016). Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy. Therapeutic Advances in Medical Oncology, 8, 48–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Field, A. K., & Biron, K. K. (1994). The end of innocence” revisited: Resistance of herpesviruses to antiviral drugs. Clinical Microbiology Reviews, 7, 1–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Field, H., & Coen, D. M. (1986). Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. Journal of Virology, 60, 286–289.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fleming-Dutra, K. E., Hersh, A. L., Shapiro, D. J., Bartoces, M., Enns, E. A., File, T. M., Finkelstein, J. A., Gerber, J. S., Hyun, D. Y., & Linder, J. A. (2016). Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. JAMA, 315, 1864–1873.

    Article  CAS  PubMed  Google Scholar 

  • Frieri, M., Kumar, K., & Boutin, A. (2017). Antibiotic resistance. Journal of Infection and Public Health, 10, 369–378.

    Article  PubMed  Google Scholar 

  • Fu, D., Calvo, J. A., & Samson, L. D. (2012). Balancing repair and tolerance of DNA damage caused by alkylating agents. Nature Reviews Cancer, 12, 104–120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • GCO. (2020). (Global Cancer Obsevatory, https://gco.iarc.fr/today/data/factsheets/cancers/17-Non-melanoma-skin-cancer-fact-sheet.pdf).

  • Gilbert, C., Bestman-Smith, J., & Boivin, G. (2002). Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resistance Updates, 5, 88–114.

    Article  CAS  PubMed  Google Scholar 

  • Gilbert, C., Azzi, A., Goyette, N., Lin, S.-X., & Boivin, G. (2011). Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet. Antimicrobial Agents and Chemotherapy, 55, 4019–4027.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gokulgandhi, M. R., Barot, M., Bagui, M., Pal, D., & Mitra, A. K. (2012). Transporter-targeted lipid prodrugs of cyclic cidofovir: A potential approach for the treatment of cytomegalovirus retinitis. Journal of Pharmaceutical Sciences, 101, 3249–3263.

    Article  CAS  PubMed  Google Scholar 

  • Gollnick, H. P., Zouboulis, C. C., Akamatsu, H., Kurokawa, I., & Schulte, A. (1991). Pathogenesis and pathogenesis related treatment of acne. The Journal of Dermatology, 18, 489–499.

    Article  CAS  PubMed  Google Scholar 

  • Gracia-Cazana, T., Gonzalez, S., & Gilaberte, Y. (2016). Resistance of nonmelanoma skin cancer to nonsurgical treatments. Part I: Topical Treatments. Actas Dermo-Sifiliográficas (english Edition), 107, 730–739.

    CAS  Google Scholar 

  • Graham, A., Furlong, S., Margoles, L. M., Owusu, K., & Franco-Paredes, C. (2010). Clinical management of leprosy reactions. Infectious Diseases in Clinical Practice, 18, 235–238.

    Article  Google Scholar 

  • Griffin, L. L., & Lear, J. T. (2016). Photodynamic therapy and non-melanoma skin cancer. Cancers, 8, 98.

    Article  PubMed Central  CAS  Google Scholar 

  • Grosset, J. H. (2001). Newer drugs in leprosy. International Journal of Leprosy and Other Mycobacterial Diseases, 69, S14–S18.

    Google Scholar 

  • Grossman, D., & Altieri, D. C. (2001). Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets. Cancer and Metastasis Reviews, 20, 3–11.

    Article  CAS  PubMed  Google Scholar 

  • Guillaume, G., Ledent, V., Moens, W., & Collard, J.-M. (2004). Phylogeny of efflux-mediated tetracycline resistance genes and related proteins revisited. Microbial Drug Resistance, 10, 11–26.

    Article  CAS  PubMed  Google Scholar 

  • Guo, Y., Song, G., Sun, M., Wang, J., & Wang, Y. (2020). Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology, 10, 107.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gutierrez, M., Supply, P., & Brosch, R. (2009). Pathogenomics of mycobacteria. Karger Publishers.

    Book  Google Scholar 

  • Guy, R. et al. (1996). Modeling acne in vitro. The Journal of Investigative Dermatology, 106(1), 176–182. https://doi.org/10.1111/1523-1747.ep12329907.

  • Hay, R. J., Johns, N. E., Williams, H. C., Bolliger, I. W., Dellavalle, R. P., Margolis, D. J., Marks, R., Naldi, L., Weinstock, M. A., & Wulf, S. K. (2014). The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. Journal of Investigative Dermatology, 134, 1527–1534.

    Article  CAS  PubMed  Google Scholar 

  • Hee Choi, Y., & Yu, A. -M. (2014). ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Current Pharmaceutical Design, 20, 793–807.

    Google Scholar 

  • Hiramatsu, K., Cui, L., Kuroda, M., & Ito, T. (2001). The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends in Microbiology, 9, 486–493.

    Article  CAS  PubMed  Google Scholar 

  • Hiramatsu, K., Katayama, Y., Matsuo, M., Sasaki, T., Morimoto, Y., Sekiguchi, A., & Baba, T. (2014). Multi-drug-resistant Staphylococcus aureus and future chemotherapy. Journal of Infection and Chemotherapy, 20, 593–601.

    Article  CAS  PubMed  Google Scholar 

  • Hofmann, M., Kiecker, F., Wurm, R., Schlenger, L., Budach, V., Sterry, W., & Trefzer, U. (2006). Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. Journal of Neuro-Oncology, 76, 59–64.

    Article  CAS  PubMed  Google Scholar 

  • Holmes, I., & Hilson, G. (1972). The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: Minimum inhibitory concentrations and bactericidal action. Journal of Medical Microbiology, 5, 251–261.

    Article  CAS  PubMed  Google Scholar 

  • Holohan, C., van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013). Cancer drug resistance: an evolving paradigm. Nature Reviews Cancer, 13, 714–726.

    Article  CAS  PubMed  Google Scholar 

  • Hori, S., & Hiramatsu, K. (1994). Mechanisms of antimicrobial resistance. Nihon rinsho. Japanese Journal of Clinical Medicine, 52, 327–331.

    CAS  PubMed  Google Scholar 

  • Hornig, J., & McGregor, A. (2014). Design and development of antivirals and intervention strategies against human herpesviruses using high-throughput approach. Expert Opinion on Drug Discovery, 9, 891–915.

    Article  CAS  PubMed  Google Scholar 

  • Hussein, M. R., Haemel, A. K., & Wood, G. S. (2003a). Apoptosis and melanoma: Molecular mechanisms. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 199, 275–288.

    Article  CAS  Google Scholar 

  • Hussein, M., Haemel, A., & Wood, G. (2003b). p53-related pathways and the molecular pathogenesis of melanoma. European Journal of Cancer Prevention, 12, 93–100.

    Article  CAS  PubMed  Google Scholar 

  • Ito, T., Katayama, Y., & Hiramatsu, K. (1999). Cloning and nucleotide sequence determination of the entire mec DNA of pre-methicillin-resistant Staphylococcus aureus N315. Antimicrobial Agents and Chemotherapy, 43, 1449–1458.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • James, S. H., & Prichard, M. N. (2014). Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance. Current Opinion in Virology, 8, 54–61.

    Article  CAS  PubMed  Google Scholar 

  • Janoly-Dumenil, A., Rouvet, I., Bleyzac, N., Morfin, F., Zabot, M.-T., & Tod, M. (2012). A pharmacodynamic model of ganciclovir antiviral effect and toxicity for lymphoblastoid cells suggests a new dosing regimen to treat cytomegalovirus infection. Antimicrobial Agents and Chemotherapy, 56, 3732–3738.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jenkins, F. J., Rowe, D.T., Rinaldo, C. R. Jr. (2003). Herpesvirus infections in organ transplant recipients. Clinical and Vaccine Immunology, 10(1), 1–7. https://doi.org/10.1128/cdli.10.1.1-7.2003. PMID: 12522031; PMCID: PMC145294.

  • Jevons, M. P. (1961). “Celbenin”-resistant staphylococci. British Medical Journal, 1, 124.

    Article  PubMed Central  Google Scholar 

  • Jiang, Y.-C., Feng, H., Lin, Y.-C., & Guo, X.-R. (2016). New strategies against drug resistance to herpes simplex virus. International Journal of Oral Science, 8, 1–6. https://doi.org/10.1038/ijos.2016.3

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kalal, B. S., Upadhya, D., & Pai, V. R. (2017). Chemotherapy resistance mechanisms in advanced skin cancer. Oncology reviews, 11.

    Google Scholar 

  • Kang, S. (2005). The mechanism of action of topical retinoids. Cutis, 75, 10.

    PubMed  Google Scholar 

  • Karimkhani, C., Dellavalle, R. P., Coffeng, L. E., Flohr, C., Hay, R. J., Langan, S. M., Nsoesie, E. O., Ferrari, A. J., Erskine, H. E., & Silverberg, J. I. (2017). Global skin disease morbidity and mortality: An update from the global burden of disease study 2013. JAMA Dermatology, 153, 406–412.

    Article  PubMed  PubMed Central  Google Scholar 

  • Katzung, B. G. (2017). Basic and clinical pharmacology 14th Edition, McGraw Hill Professional.

    Google Scholar 

  • Kewitz, S., Stiefel, M., Kramm, C. M., & Staege, M. S. (2014). Impact of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine resistance of Hodgkin’s lymphoma cells. Leukemia Research, 38, 138–143.

    Article  CAS  PubMed  Google Scholar 

  • Kim, J., Ochoa, M.-T., Krutzik, S. R., Takeuchi, O., Uematsu, S., Legaspi, A. J., Brightbill, H. D., Holland, D., Cunliffe, W. J., & Akira, S. (2002). Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. The Journal of Immunology, 169, 1535–1541.

    Article  CAS  PubMed  Google Scholar 

  • Kim, H., Suzuki, H., Matsuoka, M., Matsuba, T., Yokoyama, K., Nakajima, C., & Suzuki, Y. (2011). Molecular mechanism of the acquisition of new-quinolone resistance in Mycobacterium leprae and M. tuberculosis and rapid differentiation methods for resistant bacilli. Nihon Hansenbyo Gakkai zasshi= Japanese journal of leprosy: official organ of the Japanese Leprosy Association, 80, 17–27.

    Google Scholar 

  • Kozar, I., Margue, C., Rothengatter, S., Haan, C., & Kreis, S. (2019). Many ways to resistance: How melanoma cells evade targeted therapies. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1871, 313–322.

    Google Scholar 

  • Krishnan, G. (1976). Comparison of two concentrations of tretinoin solution in the topical treatment of acne vulgaris. The Practitioner, 216, 106–109.

    CAS  PubMed  Google Scholar 

  • Kulkarni, V., & Seydel, J. (1983). Inhibitory activity and mode of action of diaminodiphenylsulfone in cell-free folate-synthesizing systems prepared from Mycobacterium lufu and Mycobacterium leprae. Chemotherapy, 29, 58–67.

    Article  CAS  PubMed  Google Scholar 

  • LA, C. P. (2009). Mechanism of drug sensitivity and resistance in melanoma. Current Cancer Drug Targets, 9, 391–397.

    Google Scholar 

  • Laikova, K. V., Oberemok, V. V., Krasnodubets, A. M., Gal’chinsky, N. V., Useinov, R. Z., Novikov, I. A., Temirova, Z. Z., Gorlov, M. V., Shved, N. A., & Kumeiko, V. V. (2019). Advances in the understanding of skin cancer: Ultraviolet radiation, mutations, and antisense oligonucleotides as anticancer drugs. Molecules, 24, 1516.

    Google Scholar 

  • Lakhundi, S., & Zhang, K. (2018). Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clinical Microbiology Reviews, 31.

    Google Scholar 

  • Langston, A. A., Redei, I., Caliendo, A. M., Somani, J., Hutcherson, D., Lonial, S., Bucur, S., Cherry, J., Allen, A., & Waller, E. K. (2002). Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood, the Journal of the American Society of Hematology, 99, 1085–1088.

    CAS  Google Scholar 

  • Lavania, M., Singh, I., Turankar, R. P., Ahuja, M., Pathak, V., Sengupta, U., Das, L., Kumar, A., Darlong, J., Nathan, R., & Maseey, A., (2018). Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients. Journal of Global Antimicrobial Resistance, 12, 214–219.

    Google Scholar 

  • Leiter, U., & Garbe, C. (2008). Epidemiology of melanoma and nonmelanoma skin cancer—the role of sunlight. Sunlight, vitamin D and skin cancer. Springer.

    Google Scholar 

  • Levy, C., Khaled, M., & Fisher, D. E. (2006). MITF: master regulator of melanocyte development and melanoma oncogene. Trends in Molecular Medicine, 12, 406–414.

    Article  CAS  PubMed  Google Scholar 

  • Levy, J. M. M., Zahedi, S., Griesinger, A. M., Morin, A., Davies, K. D., Aisner, D. L., Kleinschmidt-Demasters, B., Fitzwalter, B. E., Goodall, M. L., & Thorburn, J. (2017). Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors. eLife, 6, e19671.

    Article  Google Scholar 

  • Leyden, J. J., Shalita, A., Thiboutot, D., Washenik, K., & Webster, G. (2005). Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment. Clinical Therapeutics, 27, 216–224.

    Article  CAS  PubMed  Google Scholar 

  • Li, N., Luo, M., Fu, Y. J., Zu, Y. G., Wang, W., Zhang, L., Yao, L. P., Zhao, C. J., & Sun, Y. (2013). Effect of corilagin on membrane permeability of Escherichia coli, Staphylococcus aureus and Candida albicans. Phytotherapy Research, 27, 1517–1523.

    Article  CAS  PubMed  Google Scholar 

  • Link, W. (2019). Principles of cancer treatment and anticancer drug development, Springer.

    Google Scholar 

  • Livermore, D. M. (2000). Antibiotic resistance in staphylococci. International Journal of Antimicrobial Agents, 16(Suppl 1), S3–10. https://doi.org/10.1016/s0924-8579(00)00299-5.

  • Loomba, P. S., Taneja, J., & Mishra, B. (2010). Methicillin and vancomycin resistant S. aureus in hospitalized patients. Journal of global infectious diseases, 2, 275.

    Google Scholar 

  • Lowe, J. (1950). Treatment of leprosy with diamino-diphenyl sulphone by mouth. Lancet, 258, 145–150.

    Google Scholar 

  • Lowrence, R. C., Subramaniapillai, S. G., Ulaganathan, V., & Nagarajan, S. (2019). Tackling drug resistance with efflux pump inhibitors: From bacteria to cancerous cells. Critical Reviews in Microbiology, 45, 334–353.

    Article  CAS  PubMed  Google Scholar 

  • Lucena, S. R., Zamarrón, A., Carrasco, E., Marigil, M. A., Mascaraque, M., Fernández-Guarino, M., Gilaberte, Y., González, S., & Juarranz, A. (2019). Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy. Scientific Reports, 9, 1–15.

    Article  CAS  Google Scholar 

  • Lynde, C. W., & Andriessen, A. (2014). Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women. Skinmed, 12, 15–21.

    PubMed  Google Scholar 

  • Magiorakos, A.-P., Srinivasan, A., Carey, R., Carmeli, Y., Falagas, M., Giske, C., Harbarth, S., Hindler, J., Kahlmeter, G., & Olsson-Liljequist, B. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection, 18, 268–281.

    Article  CAS  PubMed  Google Scholar 

  • Mandalà, M., & Romano, E. (2019). Mechanisms of Drug Resistance in Cancer Therapy. ISBN 978-3-030-10507-5. https://www.springer.com/gp/book/9783030105068.

  • Mannervik, B., Castro, V. M., Danielson, U. H., Tahir, M. K., Hansson, J., & Ringborg, U. (1987). Expression of class Pi glutathione transferase in human malignant melanoma cells. Carcinogenesis, 8, 1929–1932.

    Article  CAS  PubMed  Google Scholar 

  • Margolis, D. J., Bowe, W. P., Hoffstad, O., & Berlin, J. A. (2005). Antibiotic treatment of acne may be associated with upper respiratory tract infections. Archives of Dermatology, 141, 1132–1136.

    Article  CAS  PubMed  Google Scholar 

  • Markley, J. L., & Wencewicz, T. A. (2018). Tetracycline-Inactivating Enzymes. Frontiers in Microbiology, 9, 1058.

    PubMed  Google Scholar 

  • Mascaraque, M., Delgado-Wicke, P., Nuevo-Tapioles, C., Gracia-Cazaña, T., Abarca-Lachen, E., González, S., Cuezva, J. M., Gilaberte, Y., & Juarranz, Á. (2020). Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells. Cancers, 12, 668.

    Article  CAS  PubMed Central  Google Scholar 

  • Matono, T., Nagashima, M., Mezaki, K., Motohashi, A., Kutsuna, S., Hayakawa, K., Ohmagari, N., & Kaku, M. (2018). Molecular epidemiology of β-lactamase production in penicillin-susceptible Staphylococcus aureus under high-susceptibility conditions. Journal of Infection and Chemotherapy, 24, 153–155.

    Article  CAS  PubMed  Google Scholar 

  • McGuinness, W. A., Malachowa, N., & Deleo, F. R. (2017). Focus: infectious diseases: vancomycin resistance in Staphylococcus aureus. The Yale Journal of Biology and Medicine, 90, 269.

    CAS  PubMed  PubMed Central  Google Scholar 

  • McLaughlin, J., Watterson, S., Layton, A. M., Bjourson, A. J., Barnard, E., & McDowell, A. (2019). Propionibacterium acnes and acne vulgaris: new insights from the integration of population genetic, multi-omic, biochemical and host-microbe studies. Microorganisms, 7, 128.

    Article  CAS  PubMed Central  Google Scholar 

  • Meynadier, J., & Alirezai, M. (1998). Systemic antibiotics for acne. Dermatology, 196, 135–139.

    Article  CAS  PubMed  Google Scholar 

  • Middleton, M. R., Lunn, J., Morris, C., Rustin, G., Wedge, S., Brampton, M., Lind, M. J., Lee, S. M., Newell, D., & Bleehen, N. (1998). O 6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. British Journal of Cancer, 78, 1199–1202.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Middleton, M. R., Grob, J., Aaronson, N., Fierlbeck, G., Tilgen, W., Seiter, S., Gore, M., Aamdal, S., Cebon, J., & Coates, A. (2000). Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. Journal of Clinical Oncology, 18, 158–158.

    Article  CAS  PubMed  Google Scholar 

  • Miller, W. R., Munita, J. M., & Arias, C. A. (2014). Mechanisms of antibiotic resistance in enterococci. Expert Review of Anti-Infective Therapy, 12, 1221–1236.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mishra, H., Mishra, P. K., Ekielski, A., Jaggi, M., Iqbal, Z., & Talegaonkar, S. (2018). Melanoma treatment: from conventional to nanotechnology. Journal of Cancer Research and Clinical Oncology, 144, 2283–2302.

    Article  CAS  PubMed  Google Scholar 

  • Mitscher, L. A. (1978). The chemistry of the tetracycline antibiotics. Medicinal research series 9, Marcel Dekker, New York.

    Google Scholar 

  • Mohan, S. V., & Chang, A. L. S. (2014). Advanced basal cell carcinoma: Epidemiology and therapeutic innovations. Current Dermatology Reports, 3, 40–45.

    Article  PubMed  PubMed Central  Google Scholar 

  • Momper, J., Zhao, Y., Shapiro, R., Schonder, K., Gao, Y., Randhawa, P., & Venkataramanan, R. (2013). Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection. Transplant Infectious Disease, 15, 34–41.

    Article  CAS  PubMed  Google Scholar 

  • Moral, A., Palou, J., Lafuente, A., Molina, R., Piulachs, J., Castel, T., Trias, M., & Group, M. (1997). Immunohistochemical study of alpha, mu and pi class glutathione S transferase expression in malignant melanoma. British Journal of Dermatology, 136, 345–350.

    Google Scholar 

  • Morales, E., Cots, F., Sala, M., Comas, M., Belvis, F., Riu, M., Salvadó, M., Grau, S., Horcajada, J. P., & Montero, M. M. (2012). Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition. BMC Health Services Research, 12, 122.

    Article  PubMed  PubMed Central  Google Scholar 

  • Morello, A. M., Downing, D. T., & Strauss, J. S. (1976). Octadecadienoic acids in the skin surface lipids of acne patients and normal subjects. Journal of Investigative Dermatology, 66.

    Google Scholar 

  • Morfin, F., & Thouvenot, D. (2003). Herpes simplex virus resistance to antiviral drugs. Journal of Clinical Virology, 26, 29–37.

    Article  CAS  PubMed  Google Scholar 

  • Muthusamy, V., & Piva, T. J. (2010). The UV response of the skin: A review of the MAPK, NFκB and TNFα signal transduction pathways. Archives of Dermatological Research, 302, 5.

    Article  CAS  PubMed  Google Scholar 

  • Nguyen, F., Starosta, A. L., Arenz, S., Sohmen, D., Dönhöfer, A., & Wilson, D. N. (2014). Tetracycline antibiotics and resistance mechanisms. Biological Chemistry, 395, 559–575.

    Article  CAS  PubMed  Google Scholar 

  • Ogungbenro, K., Matthews, I., Looby, M., Kaiser, G., Graham, G., & Aarons, L. (2009). Population pharmacokinetics and optimal design of paediatric studies for famciclovir. British Journal of Clinical Pharmacology, 68, 546–560.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Olszanski, A. J. (2014). Current and future roles of targeted therapy and immunotherapy in advanced melanoma. Journal of Managed Care Pharmacy, 20, 346–356.

    Google Scholar 

  • Oztoprak, N., Cevik, M. A., Akinci, E., Korkmaz, M., Erbay, A., Eren, S. S., Balaban, N., & Bodur, H. (2006). Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections. American Journal of Infection Control, 34, 1–5.

    Article  PubMed  Google Scholar 

  • Pan, D., & Coen, D. M. (2012). Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells. Journal of Virology, 86, 4518–4526.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Papaioannou, N. E., Beniata, O. V., Vitsos, P., Tsitsilonis, O., & Samara, P. (2016). Harnessing the immune system to improve cancer therapy. Annals of translational medicine, 4.

    Google Scholar 

  • Patel, P. M., Suciu, S., Mortier, L., Kruit, W. H., Robert, C., Schadendorf, D., Trefzer, U., Punt, C. J., Dummer, R., & Davidson, N. (2011). Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032). European Journal of Cancer, 47, 1476–1483.

    Article  CAS  PubMed  Google Scholar 

  • Pearson, T., Rees, R., & Waters, M. (1975). Sulphone resistance in leprosy: A review of one hundred proven clinical cases. The Lancet, 306, 69–72.

    Article  Google Scholar 

  • Pebody, R., Andrews, N., Brown, D., Gopal, R., de Melker, H., François, G., Gatcheva, N., Hellenbrand, W., Jokinen, S., & Klavs, I. (2004). The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sexually Transmitted Infections, 80, 185–191.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Piret, J., & Boivin, G. (2011). Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrobial Agents and Chemotherapy, 55, 459–472.

    Article  CAS  PubMed  Google Scholar 

  • Piret, J., & Guy, B. (2011). Resistance of herpes simplex viruses to nucleoside analogues: Mechanisms, prevalence, and management. Antimicrobial Agents and Chemotherapy, 55(2), 459–472. https://doi.org/10.1128/AAC.00615-10.

  • Piret, J., & Boivin, G. (2014). Antiviral drug resistance in herpesviruses other than cytomegalovirus. Reviews in Medical Virology, 24, 186–218.

    Article  CAS  PubMed  Google Scholar 

  • Piskin, S., & Uzunali, E. (2007). A review of the use of adapalene for the treatment of acne vulgaris. Therapeutics and Clinical Risk Management, 3, 621.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Polycarpou, A., Walker, S. L., & Lockwood, D. N. (2013). New findings in the pathogenesis of leprosy and implications for the management of leprosy. Current Opinion in Infectious Diseases, 26, 413–419.

    Article  CAS  PubMed  Google Scholar 

  • Puhvel, S., Barfatani, M., Warnick, M., & Sternberg, T. (1964). Study of antibody levels to corynebacterium acnes: In the serum of patients with acne vulgaris, using bacterial agglutination, agar gel immunodiffusion, and immunofluorescence techniques. Archives of Dermatology, 90, 421–427.

    Article  CAS  PubMed  Google Scholar 

  • Puig, S., & Berrocal, A. (2015). Management of high-risk and advanced basal cell carcinoma. Clinical and Translational Oncology, 17, 497–503.

    Article  CAS  PubMed  Google Scholar 

  • Rathi, S. K. 2011. Acne vulgaris treatment: the current scenario. Indian Journal of Dermatology, 56, 7.

    Google Scholar 

  • Reardon, J. E., & Spector, T. (1989). Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate. Journal of Biological Chemistry, 264, 7405–7411.

    Article  CAS  PubMed  Google Scholar 

  • Reibel, F., Cambau, E., & Aubry, A. (2015). Update on the epidemiology, diagnosis, and treatment of leprosy. Medecine Et Maladies Infectieuses, 45, 383–393.

    Article  CAS  PubMed  Google Scholar 

  • Reygaert, W. (2009). Methicillin-resistant Staphylococcus aureus (MRSA): molecular aspects of antimicrobial resistance and virulence. Clinical Laboratory Science, 22, 115.

    Google Scholar 

  • Reygaert, W. C. (2018). An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiology, 4, 482.

    Google Scholar 

  • Rogalski, W. (1985). Handbook of experimental pharmacology, edited by JJ Hlavka & JH Boothe, Vol. 78. Springer.

    Google Scholar 

  • Ross, J. I., Eady, E. A., Cove, J. H., & Cunliffe, W. J. (1998). 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrobial Agents and Chemotherapy, 42, 1702–1705.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rünger, T. M., Emmert, S., Schadendorf, D., Diem, C., Epe, B., & Hellfritsch, D. (2000). Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide. Journal of Investigative Dermatology, 114, 34–39.

    Article  PubMed  Google Scholar 

  • Sagransky, M., Yentzer, B. A., & Feldman, S. R. (2009). Benzoyl peroxide: A review of its current use in the treatment of acne vulgaris. Expert Opinion on Pharmacotherapy, 10, 2555–2562.

    Article  CAS  PubMed  Google Scholar 

  • Sanada, M., Takagi, Y., Ito, R., & Sekiguchi, M. (2004). Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations. DNA Repair, 3, 413–420.

    Article  CAS  PubMed  Google Scholar 

  • Sánchez, D. P. (2003). MDR efflux pumps and antimicrobial resistance. Revista espanola de quimioterapia: publicacion oficial de la Sociedad Espanola de Quimioterapia, 16, 172.

    Google Scholar 

  • Sardana, K., & Garg, V. K. (2014). Antibiotic resistance in acne: is it time to look beyond antibiotics and P ropionobacterium acnes? International Journal of Dermatology, 53, 917–919.

    Article  PubMed  Google Scholar 

  • Schubert, A., Gentner, E., Bohn, K., Schwarz, M., Mertens, T., & Sauerbrei, A. (2014). Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes. Antiviral Research, 107, 16–22.

    Article  CAS  PubMed  Google Scholar 

  • Scollard, D. M., et al. (2006). The continuing challenges of leprosy. Clinical Microbiology Reviews, 19(2), 338–381. https://doi.org/10.1128/CMR.19.2.338-381.2006.

  • Seth, D., Cheldize, K., Brown, D., & Freeman, E. E. (2017). Global burden of skin disease: inequities and innovations. Current Dermatology Reports, 6, 204–210.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shalita, A. A., Weiss, J., Chalker, D., Ellis, C., Greenspan, A., Katz, H., Kantor, I., Millikan, L., Swinehart, T., & Swinyer, L. (1996). A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. Journal of the American Academy of Dermatology, 34, 482–485.

    Article  CAS  PubMed  Google Scholar 

  • Sharma, A. (2011). Antimicrobial resistance: No action today, no cure tomorrow. Indian Journal of Medical Microbiology, 29, 91.

    Google Scholar 

  • Shepard, C. C., Rees, R. J., Levy, L., Pattyn, S. R., Baohong, J., & Dela Cruz, E. (1986). Susceptibility of strain of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy. International Journal of Leprosy and Other Mycobacterial Diseases, 54, 11–15.

    Google Scholar 

  • Soengas, M. S., & Lowe, S. W. (2003). Apoptosis and melanoma chemoresistance. Oncogene, 22, 3138–3151.

    Article  CAS  PubMed  Google Scholar 

  • Stapleton, P. D., & Taylor, P. W. (2002). Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Science Progress, 85, 57–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tan, A. W., & Tan, H.-H. (2005). Acne vulgaris: a review of antibiotic therapy. Expert Opinion on Pharmacotherapy, 6, 409–418.

    Article  CAS  PubMed  Google Scholar 

  • Thanassi, D. G., Suh, G., & Nikaido, H. (1995). Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli. Journal of Bacteriology, 177, 998–1007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Thiboutot, D., Gollnick, H., Bettoli, V., Dréno, B., Kang, S., Leyden, J. J., Shalita, A. R., Lozada, V. T., Berson, D., & Finlay, A. (2009). New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne group. Journal of the American Academy of Dermatology, 60, S1–S50.

    Article  PubMed  Google Scholar 

  • Toriyama, K., Inoue, T., Suzuki, T., Kobayashi, T., & Ohashi, Y. (2014). Necrotizing keratitis caused by acyclovir-resistant herpes simplex virus. Case Reports in Ophthalmology, 5, 325–328.

    Article  PubMed  PubMed Central  Google Scholar 

  • Townsend, D. M., & Tew, K. D. (2003). The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene, 22, 7369–7375.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vaishnavi, C., Ganguly, N., Kumar, B., Kaur, S., & Chakravarti, R. (1985). Primary dapsone resistance in leprosy. Indian Journal of Leprosy, 57, 507–513.

    CAS  PubMed  Google Scholar 

  • Varghese, A. (2020). Acne vulgaris and antimicrobial resistance: a review. Reviews in Medical Microbiology, 31, 150–154.

    Google Scholar 

  • Velez, R., & Sloand, E. (2016). Combating antibiotic resistance, mitigating future threats and ongoing initiatives. Journal of Clinical Nursing, 25, 1886–1889.

    Article  PubMed  Google Scholar 

  • Villagra, N. A., Fuentes, J. A., Jofré, M. R., Hidalgo, A. A., García, P., & Mora, G. C. (2012). The carbon source influences the efflux pump-mediated antimicrobial resistance in clinically important Gram-negative bacteria. Journal of Antimicrobial Chemotherapy, 67, 921–927.

    Article  CAS  PubMed  Google Scholar 

  • Vossen, M. G., Gattringer, K.-B., Jäger, W., Kraff, S., & Thalhammer, F. (2014). Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration. Antimicrobial Agents and Chemotherapy, 58, 1952–1955.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Vowels, B. R., Yang, S., & Leyden, J. J. (1995). Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infection and Immunity, 63, 3158–3165.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Walker, S. L., Lockwood, D. N. J. (2006). The clinical and immunological features of leprosy. British Medical Bulletin, 77–78(1), 103–121. https://doi.org/10.1093/bmb/ldl010.

  • Walsh, T. R., Efthimiou, J., & Dréno, B. (2016). Systematic review of antibiotic resistance in acne: an increasing topical and oral threat. The Lancet Infectious Diseases, 16, e23–e33.

    Article  CAS  PubMed  Google Scholar 

  • Watson-Jones, D., Wald, A., Celum, C., Lingappa, J., Weiss, H. A., Changalucha, J., Baisley, K., Tanton, C., Hayes, R. J., & Marshak, J. O. (2010). Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. Journal of Clinical Microbiology, 48, 3496–3503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Whitby, M., McLaws, M. L., & Berry, G. (2001). Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Medical Journal of Australia, 175, 264–267.

    Article  CAS  PubMed  Google Scholar 

  • White, C., & Franco-Paredes, C. (2015). Leprosy in the 21st century. Clinical Microbiology Reviews, 28, 80–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Whitley, R. J., & Roizman, B. (2001). Herpes Simplex Virus Infections. the Lancet, 357, 1513–1518.

    CAS  Google Scholar 

  • Williams, D. L., Spring, L., Harris, E., Roche, P., & Gillis, T. P. (2000). Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance. Antimicrobial Agents and Chemotherapy, 44, 1530–1537.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Williams, D. L., & Gillis, T. P. (2004). Molecular detection of drug resistance in Mycobacterium leprae. Leprosy review, 75(2), 118–130.

    Google Scholar 

  • Wolf, J. (2001). An update of recent clinical trials examining adapalene and acne. Journal of the European Academy of Dermatology and Venereology, 15, 23–29.

    Google Scholar 

  • Yenikomshian, M. A., et al. (2015). The epidemiology of herpes zoster and its complications in Medicare cancer patients. BMC infectious diseases, 15(106). https://doi.org/10.1186/s12879-015-0810-6.

  • Zaenglein, A. L. (2018). Acne vulgaris. New England Journal of Medicine, 379, 1343–1352.

    Google Scholar 

  • Zárate Villarroel, S. G., Morales, P., Świderek, K., Bolanos-Garcia, V. M. & Bastida, A. (2019). A molecular modeling approach to identify novel inhibitors of the major facilitator superfamily of efflux pump transporters.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Management and Technology (UMT), Lahore, Pakistan

    Humaira Shah

  2. Interdisciplinary Research Centre in Biomedical Materials (IRCBM), COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan

    Sher Zaman Safi

Authors
  1. Humaira Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sher Zaman Safi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sher Zaman Safi .

Editor information

Editors and Affiliations

  1. Department of Basic Sciences, University of Veterinary and Animal Sciences, Narowal, Pakistan

    Sarfraz Ahmed

  2. Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, China

    Suvash Chandra Ojha

  3. Department of Chemistry, Bahauddin Zakariya University, Multan, Pakistan

    Muhammad Najam-ul-Haq

  4. Department of Pathobiology, University of Veterinary and Animal Sciences, Narowal, Pakistan

    Muhammad Younus

  5. Department of Chemistry, COMSATS University Islamabad, Islamabad, Pakistan

    Muhammad Zaffar Hashmi

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shah, H., Safi, S.Z. (2021). Drug Resistance in Skin Diseases. In: Ahmed, S., Chandra Ojha, S., Najam-ul-Haq, M., Younus, M., Hashmi, M.Z. (eds) Biochemistry of Drug Resistance. Springer, Cham. https://doi.org/10.1007/978-3-030-76320-6_7

Download citation

Publish with us

Policies and ethics

Search

Navigation